Patent Incorporates New Novel Improvements to Recirculating Aquaculture System and Treatment Method for Aquatic Species
The original
NaturalShrimp’s solely owned new patent 11,297,809 “Ammonia Control in a Recirculating Aquaculture System” includes enhancements to the original patent based on new novel improvements realized since applying the electrocoagulation technology for shrimp production over the last several years. This new patent further strengthens the legal protection of the Company’s electrocoagulation technology platform as applied to aquaculture both domestically and internationally.
“The issuance of this second patent reinforces NaturalShrimp’s leadership role in applying our customized electrocoagulation technology for maintaining water quality within recirculating aquaculture systems,” said
About
Forward-Looking Statements
This press release includes a number of forward-looking statements that reflect management's current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K for the fiscal year ended
Investor Relations Contact
Executive Vice President
MZ North America
Direct: 949-491-8235
SHMP@mzgroup.us
Source:
2022 GlobeNewswire, Inc., source